Datatrak and TAILRD Heart Announce Collaboration to Advance AI-Driven Healthcare and Life Sciences Clinical Research

The partnership aims to accelerate the development and delivery of evidence-based cardiovascular therapies.

Mar. 17, 2026 at 1:09am

Got story updates? Submit your updates here. ›

DATATRAK Powered by Fountayn, a cloud-based eClinical technology platform, and TAILRD Heart, an AI-powered cardiovascular care platform, have announced a strategic collaboration to bring real-world data (RWD) and artificial intelligence (AI) solutions to cardiovascular healthcare and life sciences clinical research. The collaboration will connect TAILRD's AI-driven cardiovascular analytics and patient-identification capabilities with DATATRAK's unified eSource and eClinical platform, enabling more efficient clinical trials and real-world evidence (RWE) generation across the spectrum of cardiovascular disease.

Why it matters

The partnership aims to accelerate the development and delivery of evidence-based therapies, while helping health systems improve cardiovascular outcomes at scale. By combining AI, real-world data, and proven clinical trial infrastructure, the collaboration seeks to address preventable or late-detected cardiovascular disease, which has affected many families.

The details

As part of the collaboration, DATATRAK is seeding a strategic investment in TAILRD to expand the reach of TAILRD's platform and resources. TAILRD solutions that require FDA-regulated clinical trials will leverage DATATRAK's eSource-enabled eClinical platform, including seamlessly integrated modules for eSource, EDC/CDMS, RTSM, CTMS, eTMF, eConsent, and ePRO/eCOA within a 21 CFR Part 11, HIPAA, GDPR, and GCP-compliant cloud environment. The collaboration spans multiple facets of cardiovascular care and research, including hospital and physician practice workflows, AI-powered RWD and RWE generation, virtual and hybrid clinical trials, patient recruitment and pre-screening, and AI-driven cardiovascular knowledge resources.

  • The collaboration was announced on March 16, 2026.

The players

DATATRAK Powered by Fountayn

A unified, cloud-based eClinical technology platform for global clinical trials.

TAILRD | Heart

An AI-powered cardiovascular care platform incubated at Mount Sinai Hospital.

Alex Tabatabai

CEO of DATATRAK Powered by Fountayn.

Jonathan Hart

President of TAILRD Heart.

Got photos? Submit your photos here. ›

What they’re saying

“Too many families have been affected by preventable or late‑detected cardiovascular disease, and we see a clear opportunity to combine AI, real‑world data, and proven clinical trial infrastructure to change that trajectory.”

— Alex Tabatabai, CEO, DATATRAK Powered by Fountayn (austinnews.net)

“TAILRD was built inside real health systems to solve real cardiovascular care gaps, from early detection to complex interventions and long‑term follow‑up. Partnering with DATATRAK gives us a powerful, scalable trial and data backbone so that the same infrastructure improving day‑to‑day patient care can also power the next generation of cardiovascular research and therapies.”

— Jonathan Hart, President, TAILRD Heart (austinnews.net)

The takeaway

This collaboration between DATATRAK and TAILRD Heart aims to leverage AI, real-world data, and proven clinical trial infrastructure to accelerate the development and delivery of evidence-based cardiovascular therapies, while also helping health systems improve patient outcomes at scale. By unifying AI-enabled patient identification and care pathways with an integrated eClinical platform, the partnership seeks to drive more efficient clinical trials and real-world evidence generation in the fight against heart disease.